Background Abnormalities of type I interferon signaling and production can initiate lupus development. Disturbances of nucleic acid-sensing molecules triggered autoreactivity in lupus mouse models.

The full lupus nephritis guideline includes 28 graded recommendations and 13 ungraded good practice statements. On May 7, 2025, the American College of Rheumatology (ACR) released the full guideline ...

Objective BAFF and APRIL signal through TACI, BCMA, and/or BAFF-R, and play important roles in the activation, differentiation, and/or survival of B cells, particularly antibody-secreting cells, as ...

Summary and Commentary Summary Biomarkers that reliably identify or even predict disease manifestations in systemic lupus erythematosus (SLE) are needed. In a recent issue of the Clinical Journal ...

Systemic Lupus Erythematosus: Which Drugs and When? Ronald F van Vollenhoven Disclosures Int J Clin Rheumatol. 2014;9 (4):385-394. Short-term Treatment of Active Nonrenal SLE ...

Background An increased risk of malignancy was reported in patients with Systemic Lupus Erythematosus (SLE) [1-3]. Objectives To estimate the prevalence of cancer in a Portuguese cohort of patients ...

Dr. John Watterson, MD, FRCPC, discusses diagnosis and symptoms of lupus disease. Tina Smith's Face-To-Face With 'Shocked' Mike Lee Is A Proven Way To Confront A Bully Steelers facing a major ...

Citation Frade S, O'Neill S, Greene D, Nutter E, Cameron M. Exercise as adjunctive therapy for systemic lupus erythematosus. Cochrane Database of Systematic Reviews 2023, Issue 4. Art. No.: CD014816.

Cutaneous Lupus Erythematosus Market Research Report 2025-2035, Competitive Analysis of Biogen, Bristol-Myers Squibb, Sanofi, AstraZeneca, Gilead Sciences, and Kyowa Kirin - ResearchAndMarkets.com ...

DUBLIN-- (BUSINESS WIRE)--Jun 17, 2025--Cutaneous Lupus Erythematosus Market Research Report 2025-2035, Competitive Analysis of Biogen, Bristol-Myers Squibb, Sanofi, AstraZeneca, Gilead Sciences, and ...

GSK plc (LSE/NYSE: GSK) today announced the launch of the Linked by Lupus: Optimal Care Initiative to help support individuals impacted with lupus, particularly systemic lupus erythematosus (SLE) and ...